Efficient RNA drug delivery using red blood cell extracellular vesicles.

about

Efficient RNA drug delivery using red blood cell extracellular vesicles.

Item

http://www.wikidata.org/entity/Q55384966

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

Efficient RNA drug delivery using red blood cell extracellular vesicles.

@en

Efficient RNA drug delivery using red blood cell extracellular vesicles.

@nl

type

Item

label

Efficient RNA drug delivery using red blood cell extracellular vesicles.

@en

Efficient RNA drug delivery using red blood cell extracellular vesicles.

@nl

prefLabel

Efficient RNA drug delivery using red blood cell extracellular vesicles.

@en

Efficient RNA drug delivery using red blood cell extracellular vesicles.

@nl

P1476

Efficient RNA drug delivery using red blood cell extracellular vesicles.

@en

P2093

Ajijur Azad

http://www.w3.org/2001/XMLSchema#string

Anskar Y H Leung

http://www.w3.org/2001/XMLSchema#string

Jiahai Shi

http://www.w3.org/2001/XMLSchema#string

Mengsu Yang

http://www.w3.org/2001/XMLSchema#string

Siew Mei Chin

http://www.w3.org/2001/XMLSchema#string

Victor Ma

http://www.w3.org/2001/XMLSchema#string

Waqas Muhammad Usman

http://www.w3.org/2001/XMLSchema#string

William C Cho

http://www.w3.org/2001/XMLSchema#string

Yuen San Chan

http://www.w3.org/2001/XMLSchema#string

Yuk Yan Kwok

http://www.w3.org/2001/XMLSchema#string

P2860

Trash or Treasure: extracellular microRNAs and cell-to-cell communication

Tumour microvesicles contain retrotransposon elements and amplified oncogene sequences

Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells

Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes

Overcoming cellular barriers for RNA therapeutics.

miR-200-containing extracellular vesicles promote breast cancer cell metastasis.

miR-125b-2 is a potential oncomiR on human chromosome 21 in megakaryoblastic leukemia.

Engineered red blood cells as carriers for systemic delivery of a wide array of functional probes.

MicroRNA-125b confers the resistance of breast cancer cells to paclitaxel through suppression of pro-apoptotic Bcl-2 antagonist killer 1 (Bak1) expression.

Conserved regulation of p53 network dosage by microRNA-125b occurs through evolving miRNA-target gene pairs.

P2888

s41467-018-04791-8

P304

2359

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/S41467-018-04791-8

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2018-06-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1104570279

http://www.w3.org/2001/XMLSchema#string

P698

29907766

http://www.w3.org/2001/XMLSchema#string

P921

drug delivery

P932

6004015

http://www.w3.org/2001/XMLSchema#string